Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5080755
Max Phase: Preclinical
Molecular Formula: C52H69N7O7S
Molecular Weight: 936.23
Molecule Type: Unknown
Associated Items:
ID: ALA5080755
Max Phase: Preclinical
Molecular Formula: C52H69N7O7S
Molecular Weight: 936.23
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](NC(=O)C2(C)CC2)C(C)(C)C)c(OCCCCCCCCCCCC(=O)Nc2ccc(C(=O)Nc3ccccc3N)cc2)c1
Standard InChI: InChI=1S/C52H69N7O7S/c1-34-45(67-33-55-34)36-20-21-37(31-54-48(63)42-30-39(60)32-59(42)49(64)46(51(2,3)4)58-50(65)52(5)26-27-52)43(29-36)66-28-16-12-10-8-6-7-9-11-13-19-44(61)56-38-24-22-35(23-25-38)47(62)57-41-18-15-14-17-40(41)53/h14-15,17-18,20-25,29,33,39,42,46,60H,6-13,16,19,26-28,30-32,53H2,1-5H3,(H,54,63)(H,56,61)(H,57,62)(H,58,65)/t39-,42+,46+/m1/s1
Standard InChI Key: ORWXCOUYCBSWFL-XASURKDDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 936.23 | Molecular Weight (Monoisotopic): 935.4979 | AlogP: 8.78 | #Rotatable Bonds: 23 |
Polar Surface Area: 205.08 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 12.28 | CX Basic pKa: 3.24 | CX LogP: 7.10 | CX LogD: 7.10 |
Aromatic Rings: 4 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: -0.59 |
1. Smalley JP, Baker IM, Pytel WA, Lin LY, Bowman KJ, Schwabe JWR, Cowley SM, Hodgkinson JT.. (2022) Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells., 65 (7.0): [PMID:35293758] [10.1021/acs.jmedchem.1c02179] |
Source(1):